BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022
- PMID: 36504313
- DOI: 10.1111/hiv.13446
BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022
Similar articles
-
IN BRIEF: BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022.HIV Med. 2022 Oct;23 Suppl 3:3-14. doi: 10.1111/hiv.13399. HIV Med. 2022. PMID: 36192083 No abstract available.
-
British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012.HIV Med. 2012 Sep;13 Suppl 2:1-85. doi: 10.1111/j.1468-1293.2012.01029.x. HIV Med. 2012. PMID: 22830364
-
Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion--reply.JAMA Intern Med. 2013 Mar 25;173(6):476-7. doi: 10.1001/jamainternmed.2013.2784. JAMA Intern Med. 2013. PMID: 23529555 No abstract available.
-
1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Writing Committee.Lancet. 1998 Jul 25;352(9124):314-6. doi: 10.1016/s0140-6736(98)04084-7. Lancet. 1998. PMID: 9690427 Review.
-
Update on antiretroviral treatment during primary HIV infection.Expert Rev Anti Infect Ther. 2014 Jul;12(7):793-807. doi: 10.1586/14787210.2014.913981. Epub 2014 May 7. Expert Rev Anti Infect Ther. 2014. PMID: 24803105 Review.
Cited by
-
Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen.Viruses. 2024 Jul 5;16(7):1083. doi: 10.3390/v16071083. Viruses. 2024. PMID: 39066245 Free PMC article.
-
Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study.Clin Infect Dis. 2025 Jun 4;80(5):1103-1113. doi: 10.1093/cid/ciae523. Clin Infect Dis. 2025. PMID: 39465685 Free PMC article.
-
Pregnancy Management in HIV Viral Controllers: Twenty Years of Experience.Pathogens. 2024 Apr 10;13(4):308. doi: 10.3390/pathogens13040308. Pathogens. 2024. PMID: 38668263 Free PMC article.
-
Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review.Viruses. 2024 Jun 12;16(6):951. doi: 10.3390/v16060951. Viruses. 2024. PMID: 38932243 Free PMC article. Review.
-
Unlocking the Keys to Swift HIV Treatment: A Qualitative Exploration of Rapid Antiretroviral Therapy Initiation Among People Living with HIV in China.Patient Prefer Adherence. 2025 May 30;19:1603-1613. doi: 10.2147/PPA.S527229. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40463790 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical